Example: Heart Attack

Clinical Trials on Atrophy

Total 2410 results

NCT02497547

Completed

An Efficacy Study of Vagitocin in Postmenopausal Women With Symptoms of Vaginal Atrophy

Conditions: Atrophy
NCT04177134

Recruiting

French Register of Patients With Spinal Muscular Atrophy

Conditions: Spinal Muscular Atrophy
NCT01694095

Completed

Evolution and Risk Factors Associated With Geographic Atrophy Progression

Conditions: Geographic Atrophy
NCT02781623

Enrolling by invitation

Quantifying Quadriceps Atrophy Following Tibial Plateau Fracture

Conditions: Atrophy
NCT04487392

Not yet recruiting

Photobiomodulation Effect on Vulvovaginal Atrophy in Postmenopausal Women.

Conditions: Vulvovaginal Atrophy
NCT04717245

Completed

Comparative Study: Vaginal Promestriene Use, Fractional CO2 LASER and Radiofrequency in the Vaginal Atrophy Treatment

Conditions: Vaginal Atrophy
NCT03952806

Active, not recruiting

Study of BHV-3241 in Subjects With Multiple System Atrophy

Conditions: Multiple System Atrophy
NCT04657536

Not yet recruiting

Evaluating the Efficacy of Temperature-controlled Radiofrequency (TRF) in the Treatment of Vulvovaginal Atrophy.

Conditions: Postmenopausal Vulvovaginal Atrophy
NCT03217578

Recruiting

Neonatal Spinal Muscular Atrophy (SMA) Screening

Conditions: Spinal Muscular Atrophy
NCT04680143

Recruiting

Systemic Erythropoietin Injection in Patients Having Optic Atrophy

Conditions: Optic Atrophy
NCT02773771

Unknown status

Strategies to Reduce Organic Muscle Atrophy in the Intensive Care Unit

Conditions: Muscle Atrophy
NCT04607707

Recruiting

Women's Satisfaction and Adherence to Vulvovaginal Atrophy Treatments

Conditions: Vulvovaginal Atrophy
NCT04766957

Recruiting

Pilot Clinical Trial of IDRACARE® in Moderate to Severe Symptoms of Vulvovaginal Atrophy

Conditions: Vulvovaginal Atrophy
NCT02123186

Completed

Newborn Screening for Spinal Muscular Atrophy

Conditions: Spinal Muscular Atrophy
NCT02419729

Completed

Evaluation of Fractional CO2 Laser Treatment Efficacy and Comparison to Vaginal Estrogen Therapy in Postmenopausal Women With Vulvovaginal Atrophy

Conditions: Vulvovaginal Atrophy
NCT01502527

Completed

A Twelve Week Study to Investigate the Efficacy of Femarelle®, for the Treatment of Post Menopausal Vaginal Atrophy

Conditions: Vulvo Vaginal Atrophy
NCT04574999

Completed

Study to Determine Efficacy & Safety of a Low Concentration Estriol (0.005%) in Postmenopausal Vaginal Atrophy.

Conditions: Vaginal Atrophy
NCT03998722

Completed

Evaluation of VagiVital® for Treatment of Vaginal Atrophy

Conditions: Vaginal Atrophy
NCT04629885

Completed

Study to Evaluate Efficacy of Vagitocin in Postmenopausal Women With Vulvovaginal Atrophy Symptoms

Conditions: Vulvovaginal Atrophy
NCT03797781

Completed

Protein Ingestion and Skeletal Muscle Atrophy

Conditions: Muscle Atrophy
NCT01846442

Completed

Topical DHEA Against Vaginal Atrophy

Conditions: Vaginal Atrophy
NCT04159493

Not yet recruiting

A Randomized Controlled Phase 2 Study to Determine Lowest Efficacious Dose of Ovestin in Vulvar and Vaginal Atrophy

Conditions: Vaginal Atrophy
NCT02268552

Active, not recruiting

An Open Label Study of LMI070 (Branaplam) in Type 1 Spinal Muscular Atrophy (SMA)

Conditions: Spinal Muscular Atrophy
NCT03493126

Recruiting

Vaginal Estrogen on Postpartum Atrophy, Perineal Pain, and Sexual Function

Conditions: Vaginal Atrophy
NCT04219722

Recruiting

Efficacy and Safety of Hyaluronic Acid Injection on Symptoms of Vulvovaginal Atrophy in Postmenopausal Women

Conditions: Vulvovaginal Atrophy